Albuterol
Active ingredient · 2 therapeutic classes
Sold as AIROMIR · PMS-SALBUTAMOL · VENTOLIN HFA · COMBIVENT UDVS · SALBUTAMOL HFA
- Drug class
- Selective Beta-2-Adrenoreceptor Agonists
- Availability
- Prescription only
- Routes
- Oral, Respiratory (Inhalation), Inhalation, Intravenous
- Markets covered
- 3
- Products on record
- 82
- FDA reports (12 mo)
- 23,205
Overview
Plain-language summary, compiled from the cited regulatory records
Albuterol is a medication belonging to the drug class of selective beta-2-adrenoreceptor agonists [1]. It is approved for treating or preventing bronchospasm in adult and pediatric patients aged 4 years and older who have reversible obstructive airway disease [1]. Additionally, albuterol is indicated for the prevention of exercise-induced bronchospasm in the same patient population [1].
This medication is available under various brand names, including VENTOLIN HFA [1]. In the past 12 months, there have been 23,205 adverse event reports associated with albuterol [2]. The most frequently reported issues include dyspnea, problems with the device delivery system, drug dose omission by the device, incorrect technique in product usage, and off-label use [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 41 | May 29, 2026 |
| US United States | FDA | 25 | April 14, 2026 |
| CA Canada | Health Canada | 16 | June 1, 2026 |
GBUnited Kingdom· MHRA
41 products
Uses
Ipramol Steri-Neb is indicated in adults, adolescents and children aged 12 years and above. Ipramol Steri-Neb is indicated for the management of bronchospasm in patients suffering from chronic obstructive pulmonary disease (COPD) who require regular treatment with both ipratropium bromide and salbutamol.
How to take
USUnited States· FDA
25 products
Uses
INDICATIONS AND USAGE
Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.
How to take
CACanada· Health Canada
16 products
Uses
37 COMBIVENT RESPIMAT Product Monograph November 7, 2019 Page 3 of 44 PrCOMBIVENT® RESPIMAT® Ipratropium Bromide (as Monohydrate) and Salbutamol (as Salbutamol Sulfate) Inhalation Solution PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Nonmedicinal Ingredients Oral Inhalation Inhalation Solution / Each actuation delivers 20 mcg ipratropium bromide (monohydrate) and 100 mcg salbutamol (as salbutamol sulfate) from the mouth piece.
Benzalkonium chloride, edetate disodium, hydrochloric acid and purified water INDICATIONS AND CLINICAL USE COMBIVENT RESPIMAT (ipratropium bromide and salbutamol sulfate) inhalation solution is indicated for treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
Pediatrics:
The efficacy and safety in children and adolescents under 18 years has not been established. COMBIVENT RESPIMAT is not indicated in this patient population.
Drug interactions
Known interactions involving Albuterol. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL005300961 · revised May 29, 2026
- [2]FDA DailyMed · 230d66fc-f62c-42… · revised April 14, 2026 [PDF]
- [3]Health Canada (DPD) · 02419106 · revised March 31, 2026
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.